Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Appili Therapeutics Inc - Ordinary Shares - Class A market cap is $132,400.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Appili Therapeutics Inc - Ordinary Shares - Class A 52 week high is $0.02 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Appili Therapeutics Inc - Ordinary Shares - Class A 52 week low is $0.001 as of November 18, 2026.
Appili Therapeutics Inc - Ordinary Shares - Class A stock price today is $0.001.
Appili Therapeutics Inc - Ordinary Shares - Class A stock price yesterday was $0.002.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Appili Therapeutics Inc - Ordinary Shares - Class A's P/E ratio is -0.03.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Appili Therapeutics Inc - Ordinary Shares - Class A P/B ratio is -0.009.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Appili Therapeutics Inc - Ordinary Shares - Class A 50-day moving average is $0.0059.
Appili Therapeutics Inc - Ordinary Shares - Class A has 7 employees.